IRIS

Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 21.650 a 21.669 di 22.680
Titolo Data di pubblicazione Autore(i) File
Tubercolosi osteoarticolare 1-gen-2004 De santis, Maria
Tuberculosis care among refugees arriving in Europe : a ERS/WHO Europe Region survey of current practices 1-gen-2016 Dara, M.; Solovic, I.; Sotgiu, G.; D'Ambrosio, L.; Centis, R.; Tran, R.; Goletti, D.; Duarte, R.; Aliberti, S.; de Benedictis, F. M.; Bothamley, G.; Schaberg, T.; Abubakar, I.; Teixeira, V.; Ward, B.; Gratziou, C.; Migliori, G. B.
Tuberous breast: Morphological study and overview of a borderline entity 1-gen-2011 Klinger, M.; Caviggioli, F.; Klinger, F.; Villani, F.; Arra, E.; Di Tommaso, L.
Tumor Accumulation of Radiolabeled Bevacizumab due to Targeting of Cell- and Matrix-Associated VEGF-A Isoforms 1-gen-2009 Stollman, Th; Scheer, Mgw; Franssen, Gm; Verrijp, Kn; Oyen, W; Ruers, Tjm; Leenders, Wpj; Boerman, Oc
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 1-gen-2016 Rimassa, L; Abbadessa, G; Personeni, N; Porta, C; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, Jl; Van Vlierberghe, H; Trojan, J; De Toni, En; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Lamar, Me; Wang, Y; Shuster, D; Schwartz, Be; Santoro, A
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy 1-gen-2015 Woliner-van der Weg, W; Schoffelen, R; Hobbs, Rf; Gotthardt, M; Goldenberg, Dm; Sharkey, Rm; Slump, Ch; van der Graaf, Wta; Oyen, W; Boerman, Oc; Sgouros, G; Visser, Ep
Tumor associated macrophages and neutrophils in cancer 1-gen-2013 Galdiero, Mr; Bonavita, E; Barajon, I; Garlanda, C; Mantovani, A; Jaillon, S
Tumor associated macrophages and neutrophils in tumor progression. 1-gen-2012 Galdiero, Mr; Garlanda, C; Jaillon, S; Marone, G; Mantovani, A
Tumor Associated Macrophages: toward a better understanding of their cancer driver capability in Malignant Pleural Mesothelioma. 1-gen-2019 Digifico, E; Erreni, M; Ceresoli, Gl; Roncalli, M; Frapolli, R; D'Incalci, M; Belgiovine, C; Allavena, P
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma 1-gen-2017 Rimassa, L; Reig, M; Abbadessa, G; Peck-Radosavljevic, M; Harris, W; Zagonel, V; Pastorelli, D; Rota Caremoli, E; Porta, C; Damjanov, N; Patel, N; Daniele, B; Lamar, M; Schwartz, B; Goldberg, T; Santoro, A; Bruix, J
Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic F-18 Fluorodeoxyglucose PET 1-gen-2017 Meijer, Twh; de Geus-Oei, Lf; Visser, Ep; Oyen, W; Looijen-Salamon, Mg; Visvikis, D; Verhagen, Aftm; Bussink, J; Vriens, D
Tumor enucleoresection in robot-assisted partial nephrectomy 1-gen-2009 Mottrie, A; Koliakos, N; Denaeyer, G; Willemsen, P; Buffi, N; Schatteman, P; Fonteyne, E
TUMOR GRADE IMPROVES THE ABILITY OF THE PROGNOSTIC ABILITY OF AJCC STAGES IN PATIENTS WITH PENILE CARCINOMA 1-gen-2010 Thuret, R; Jeldres, C; Budaus, L; Lughezzani, G; Liberman, D; Sun, M; Patard, Jj; Shariat, Sf; Graefen, M; Montorsi, F; Perrotte, P; Karakiewicz, P
Tumor Grade Improves the Prognostic Ability of American Joint Committee on Cancer Stage in Patients With Penile Carcinoma 1-gen-2011 Thuret, R; Sun, Mx; Abdollah, F; Budaus, L; Lughezzani, G; Liberman, D; Morgan, M; Johal, R; Jeldres, C; Latour, M; Shariat, Sf; Iborra, F; Guiter, J; Patard, Jj; Perrotte, P; Karakiewicz, Pi
Tumor hypoxia as a mechanism of resistance to bevacizumab in a murine model 1-gen-2012 Heijmen, L; Boerman, Oc; Punt, Cja; Ter Voert, E; Oyen, W; Bussink, J; Sweep, Fcgj; Laverman, P; Span, P; de Geus-Oei, Lf; Heerschap, A; Van Laarhoven, Hwm
Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma 1-gen-2021 Hiltbrunner, Stefanie; Mannarino, Laura; Kirschner, Michaela B; Opitz, Isabelle; Rigutto, Angelica; Laure, Alexander; Lia, Michela; Nozza, Paolo; Maconi, Antonio; Marchini, Sergio; D'Incalci, Maurizio; Curioni-Fontecedro, Alessandra; Grosso, Federica
Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal status 1-gen-2022 Kotsafti, Andromachi; Fassan, Matteo; Cavallin, Francesco; Angerilli, Valentina; Saadeh, Luca; Cagol, Matteo; Alfieri, Rita; Pilati, Pierluigi; Castoro, Carlo; Castagliuolo, Ignazio; Scarpa, Melania; Scarpa, Marco
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. 1-gen-2015 Shindoh, J; de Aretxabala, X; Aloia, Ta; Roa, Jc; Roa, I; Zimmitti, G; Javle, M; Conrad, C; Maru, Dm; Aoki, T; Vigano, L; Ribero, D; Kokudo, N; Capussotti, L; Vauthey, Jn.
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fraction. 1-gen-1990 Gion, M; Tremolada, C; Mione, R; Dittadi, R; Della Palma, P; Castoro, C; Ruol, A; Nosadini, A; Peracchia, A; Bruscagnin, G
The tumor microenvironment and immune milieu of cholangiocarcinoma 1-gen-2019 LLEO DE NALDA, Ana
Mostrati risultati da 21.650 a 21.669 di 22.680
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile